JunZeJun appointed to Sinopharm’s alternative legal panel

JunZeJun has been appointed to the alternative legal panel of the Sinopharm Group, following a stringent and prudent selection process. Under the direct administration of the SASAC (State-owned Assets Supervision and Administration Commission) of the State Council, Sinopharm is the China's largest medical and pharmaceutical group with the most comprehensive industrial chains and the best integral capabilities. The Group's primary businesses include the research and development, manufacture, distribution and retail of relevant health products on sickness prevention, treatment, diagnosis and nursing. The appointment has not only laid a solid foundation on the deepening cooperation between both parties but also opened a door for JunZeJun to further develop its advantages in the field of medicine.